Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer (Therapy)
Cardiac and Vascular Morbidity in Women Receiving Adjuvant Tamoxifen for Breast Cancer in a Randomised Trial
November 13th, 1995
According to the authors' abstract of an article published in British Medical Journal, "Objective: To determine any cardiac or vascular morbidity associated with long term treatment with tamoxifen given after mastectomy for primary breast cancer. Designs: Cohort study using linkage between database of a randomised trial and statistics of Scottish hospital inpatients to identify episodes of cardiac and vascular morbidity. Setting: NHS hospitals in Scotland. Subjects: 1312 women who had undergone mastectomy for breast cancer and who were randomised either to a treatment group to receive adjuvant tamoxifen or to a control group to be given tamoxifen only...
Source: Women's Health Weekly (1995-11-13)
|
|
Advertisement |
|
|
